论文部分内容阅读
目的观察紫龙金片联合化疗治疗中晚期非小细胞肺癌的临床疗效。方法将48例中晚期非小细胞肺癌患者随机分为2组:治疗组(25例)给予紫龙金片联合多西他赛加顺铂方案化疗,对照组(23例)给予单纯多西他赛加顺铂方案化疗。治疗2个周期进行疗效评价。结果治疗组在KPS评分、体质量、细胞免疫功能及化疗毒副作用方面与对照组比较差异有统计学意义(P<0.05)。结论紫龙金片联合化疗治疗非小细胞肺癌,可以改善患者的生活质量,减轻化疗的毒副作用。
Objective To observe the clinical curative effect of combined treatment of middle and late stage non-small cell lung cancer. Methods Forty-eight patients with advanced non-small cell lung cancer were randomly divided into two groups: the treatment group (25 cases) was treated with combination of radix-sequins and docetaxel plus cisplatin, and the control group (23 cases) received docetaxel Sega cisplatin chemotherapy. Treatment 2 cycles for efficacy evaluation. Results There was significant difference between the treatment group and the control group in terms of KPS score, body weight, cellular immune function and chemotherapy side effects (P <0.05). Conclusion Zilongjian combined with chemotherapy for non-small cell lung cancer can improve the quality of life of patients and reduce the side effects of chemotherapy.